Issue 2026-11-19 · Industry · 应用 · 研究
Anthropic board director Vas Narasimhan bets AI can help Novartis solve 'biological latency'

Vas Narasimhan, an Anthropic board director and Novartis leader, bets that AI can help Novartis tackle 'biological latency' and speed up biopharma R&D.
Read original ↗- Anthropic Sets Up Biology Lab Where Claude Guides Robots Through Drug Experiments
- Asian shares fall on AI fears despite Anthropic IPO pop
- Anthropic Valuation Tests Promise to Develop AI Responsibly
- Fireworks AI says firms can mostly skip pricey frontier models
- OpenAI Opens Cyber Models as Google Slashes AI Prices